A conflict has emerged among lawyers involved in the Ozempic litigation against Wegovy and Mounjaro drugmakers, despite a federal judge's call for civility a month prior. The dispute centers around the formation of a proposed leadership team consisting of 30 plaintiffs' attorneys. This squabble has raised significant questions regarding the criteria for selecting leaders in such comprehensive cases. In response to accusations of exclusion, the proposed co-lead lawyers expanded their team by including two additional attorneys, aiming to demonstrate inclusivity and teamwork within the litigation process.